IceCure Medical Revenue 2020-2023 | ICCM
IceCure Medical revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| IceCure Medical Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $3 |
| 2022 | $3 |
| 2021 | $4 |
| 2020 | $4 |
| 2019 | $2 |
| IceCure Medical Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-09-30 | |
| 2023-03-31 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | |
| 2021-09-30 | $1 |
| 2021-06-30 | |
| 2021-03-31 | $1 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.055B | $0.003B |
| IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.503B | 15.75 |
| Cencora (COR) | United States | $44.240B | 17.25 |
| ICON (ICLR) | Ireland | $26.547B | 25.06 |
| DiDi Global (DIDIY) | China | $22.698B | 0.00 |
| Avantor (AVTR) | United States | $17.124B | 25.21 |
| CochLear (CHEOY) | Australia | $14.770B | 0.00 |
| Revvity (RVTY) | United States | $13.241B | 23.23 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.178B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.576B | 41.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.562B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 22.93 |
| Solventum (SOLV) | United States | $10.784B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.508B | 48.62 |
| Organon (OGN) | United States | $5.568B | 5.28 |
| Bausch + Lomb (BLCO) | Canada | $5.269B | 21.11 |
| Doximity (DOCS) | United States | $4.449B | 33.12 |
| PACS (PACS) | United States | $4.257B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.440B | 31.48 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $2.979B | 31.21 |
| GoodRx Holdings (GDRX) | United States | $2.728B | 103.86 |
| Progyny (PGNY) | United States | $2.550B | 43.90 |
| Premier (PINC) | United States | $2.383B | 8.92 |
| AMN Healthcare Services Inc (AMN) | United States | $2.287B | 9.06 |
| NovoCure (NVCR) | Jersey | $2.265B | 0.00 |
| Agilon Health (AGL) | United States | $2.180B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.992B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.647B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.348B | 0.00 |
| Embecta (EMBC) | United States | $0.793B | 5.39 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.690B | 7.32 |
| Auna S.A (AUNA) | Luxembourg | $0.648B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.566B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.553B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.434B | 43.30 |
| MultiPlan (MPLN) | United States | $0.405B | 0.00 |
| ModivCare (MODV) | United States | $0.382B | 7.15 |
| LifeMD (LFMD) | United States | $0.351B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 18.67 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| Sharecare (SHCR) | United States | $0.275B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.124B | 41.67 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |